News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
VIVUS, Inc.'s Wilson Says Erection Drug Works in 80 Percent of Men in 15 Minutes
January 13, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Vivus Inc.’s experimental impotence drug Avanafil helped 80 percent of men achieve erections and two-thirds to have intercourse, Chief Executive Officer Leland Wilson said.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
MORE ON THIS TOPIC
Cancer
AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study
September 4, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer
September 3, 2026
·
2 min read
·
Heather McKenzie
Lung cancer
Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again
September 3, 2026
·
2 min read
·
Annalee Armstrong
Rare diseases
Ultragenyx’s ‘high-risk’ Angelman bet fails, cratering stock and forcing strategic review
September 3, 2026
·
2 min read
·
Tristan Manalac